<p><strong>Mounjaro 15 mg Solution for Injection in Prefilled Pen</strong> is a prescription medication indicated for the treatment of adults with type 2 diabetes mellitus to improve blood sugar (glucose) control, used as an adjunct to diet and exercise. It is also approved for chronic weight management in adults with obesity or overweight with at least one weight-related comorbid condition, such as high blood pressure, type 2 diabetes, or high cholesterol.</p><br/><p><strong>Benefits of Use:</strong></p><ul><li><p>Significantly lowers A1C levels, enhancing glycemic control in adults with type 2 diabetes.</p></li><li><p>Promotes substantial and sustained weight loss in individuals with obesity or overweight.</p></li><li><p>Offers convenient once-weekly administration with an easy-to-use prefilled pen.</p></li><li><p>Addresses both blood sugar management and weight reduction with a single therapy.</p></li></ul><br/><p><strong>How to Use:</strong></p><ul><li><p>Mounjaro 15 mg is administered once weekly via subcutaneous injection into the abdomen, thigh, or upper arm.</p></li><li><p>The injection should be given on the same day each week, at any time of day, independent of meals.</p></li><li><p>Rotate the injection site with each dose to prevent skin irritation.</p></li><li><p>Carefully follow the detailed instructions provided by your healthcare provider for proper administration.</p></li><li><p>Do not share your Mounjaro pen with others, as this carries a risk of infection or disease transmission.</p></li></ul><br/><p><strong>Caution & Warnings:</strong></p><ul><li><p><strong>Risk of Thyroid C-Cell Tumors:</strong> Inform your doctor if you have a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).</p></li><li><p>Common side effects may include nausea, vomiting, diarrhea, abdominal pain, and constipation.</p></li><li><p>Consult your doctor about all existing medical conditions, especially if you have a history of pancreatitis, kidney disease, or diabetic retinopathy, and list all current medications.</p></li><li><p>Mounjaro is not indicated for the treatment of type 1 diabetes.</p></li><li><p>Always keep this medication out of the sight and reach of children.</p></li><li><p>Do not use the pen if the solution appears discolored, cloudy, or contains visible particles.</p></li></ul><br/><p><strong>Ingredients:</strong></p><ul><li><p><strong>Active Ingredient:</strong> Tirzepatide 15 mg.</p></li><li><p><strong>Excipients:</strong> Sodium phosphate dibasic heptahydrate, sodium chloride, hydrochloric acid (for pH adjustment), sodium hydroxide (for pH adjustment), and water for injection.</p></li></ul><br/><p><strong>Product Details:</strong></p><ul><li><p><strong>Form:</strong> Solution for Injection</p></li><li><p><strong>Strength:</strong> 15 mg Tirzepatide</p></li><li><p><strong>Package Size:</strong> 4 Prefilled Pens per Box</p></li><li><p><strong>Manufacturer:</strong> Eli Lilly and Company</p></li><li><p><strong>Storage:</strong> Store in refrigerator (2C to 8C). If needed, it can be stored at room temperature (8C to 30C) for a maximum of 21 days.</p></li></ul>